20 YEARS OF PROFESSIONAL & DEDICATED SERVICE TO GLOBAL CUSTOMERS

Custom Manufacturing, Project Outsourcing, your Trusted Partner from China

High-Purity Heparinase I: Essential for Biomedical Research & Drug Discovery

In the complex landscape of biomedical research and drug discovery, access to high-quality reagents is non-negotiable. Heparanase I (CAS 9025-39-2), an enzyme crucial for the breakdown of heparan sulfate, is one such essential component. Its role in modulating the extracellular matrix and influencing cellular signaling pathways makes it a key player in understanding numerous physiological and pathological processes, including inflammation, wound healing, and particularly cancer.

Heparanase I's enzymatic action on heparan sulfate proteoglycans (HSPGs) impacts a wide array of cellular behaviors. It can liberate growth factors bound to HSPGs, thereby promoting angiogenesis and influencing cell migration. For researchers investigating these mechanisms, the purity and reliability of the enzyme are of utmost importance. Impurities or variations in enzyme activity can lead to misleading results and hinder the progress of scientific inquiry.

NINGBO INNO PHARMCHEM CO.,LTD. recognizes the critical need for dependable biochemicals. As a prominent manufacturer and supplier, we offer Heparinase I with a guaranteed purity of 99%. This high standard ensures that our customers, whether they are academic researchers, biotechnological firms, or pharmaceutical companies, can perform their work with the highest degree of confidence. Our commitment extends beyond just product quality; we strive to be a steadfast partner in your research endeavors.

When you choose to buy Heparinase I from NINGBO INNO PHARMCHEM CO.,LTD., you are opting for a product that is manufactured under stringent quality controls. This enzyme is an invaluable tool for studies focusing on matrix remodeling, inflammatory diseases, and the complex cascade of cancer metastasis. For those seeking a reliable supplier of this essential enzyme, we invite you to request a quote and learn more about how we can support your critical projects.

Our goal is to facilitate scientific breakthroughs by providing the foundational tools. Heparinase I is central to many cutting-edge research areas, and we are proud to be a key provider in the global market.

Manufacturing Facilities

NINGBO INNO PHARMCHEM CO.,LTD. was established in 2007. It is committed to the R&D, production and sales of raw materials, pharmaceutical intermediates and fine chemicals. We striving to create a high-efficiency and high-quality integrated chemical service platform to better serve domestic and foreign customers.

Professional Export Experience

to Global Customers

WHY CHOSE US?

1. 20 years of R&D, manufacturing and sales experience, serving customers in 60 countries and regions around the world;

2. Own R&D laboratory, pilot platform and large-scale production workshop, which can meet the audit requirements of global customers;

3. We can satisfy customers' perfect transition from small scale lab requirements (gram level) to commercialization requirements (hundred tons level).

FAQ

  • A: We don't have Minimum Order Quantity, exact quantity should be provided before quotation for us to calculate the exact cost.

  • A: We don't provide free samples due to lots of request and expensive international courier's cost, we can deduct the sample charge after commercial order placed.

  • A: Our payment terms: Small or sample order: T/T IN ADVANCE. Commercial order: First order should be by T/T IN ADVANCE or L/C at sight, and following orders T/T 30~90days is acceptable subject to approval of credit application.

CONTACT US
Should you need to contact us; you may call during regular business hours, Monday through Friday, 8am – 6 pm.
NINGBO INNO PHARMCHEM CO.,LTD.
Address: No.163 Ruiqing Rd.,Ningbo 315000 China
Phone: 86-574-87319282
Fax: 86-574-27912196
SEND US AN EMAIL

NAME*

EMAIL*

COMPANY

COUNTRY*

MESSAGE*

Previous: Understanding Heparanase I: A Key Enzyme for Cancer Research

Next: Procuring Heparinase I: A Strategic Decision for Pharma Manufacturers

All Rights Reserved